PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX:HEB) today commented on recent news of the internal operating irregularities within BDO Seidman (“BDO”) and the resultant restatement of the Hemispherx financial results for fiscal years including fiscal 2004.
